Heat Shock Proteins in Neuroprotection: Molecular Mechanisms, Therapeutic Induction by Hyperthermia, and Clinical Implications

Abstract

Heat shock proteins (HSPs) are ubiquitous molecular chaperones that maintain proteostasis by assisting in protein folding, preventing aggregation, and facilitating the refolding or clearance of damaged proteins. Dysregulated proteostasis is a hallmark of neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s, ALS).

Controlled hyperthermia—particularly in the fever range—induces HSP expression, offering a non-pharmacologic strategy to mitigate protein misfolding, reduce neuroinflammation, and support mitochondrial function. Recent reviews co-authored by Dr. Marc Abreu, MD consolidate mechanistic and translational evidence that targeted hyperthermia upregulates HSP70 and HSP90, modulating immune and neural pathways relevant to neurodegeneration and oncology. Frontiers Building on Abreu’s discovery of brain thermal tunnels (btt)—an anatomic-physiologic pathway enabling precise, brain-guided thermodynamic interventions—these insights provide a framework safely integrating HSP induction into clinical protocols. YaleNews

Keywords: heat shock proteins, HSP70, HSP90, hyperthermia, neurodegeneration, proteostasis, brain thermodynamics, btt.

1. Introduction

Protein misfolding and toxic aggregate accumulation are central to the pathobiology of multiple neurodegenerative disorders. HSPs (notably HSP70 and HSP90) act as ATP-dependent chaperones that stabilize nascent polypeptides, refold misfolded proteins, and cooperate with proteasome/autophagy systems.

Fever-range hyperthermia (~38–40 °C at tissue level) robustly induces HSPs, improving mitochondrial function and attenuating neuroinflammatory signaling. PubMed

Abreu and collaborators have synthesized evidence supporting therapeutic hyperthermia as a means to target HSP pathways relevant to neurodegenerative disease biology, highlighting translational potential of controlled use of temperature modulation.

2. Molecular Biology of Heat Shock Proteins

2.1 HSP70 family

HSP70 recognizes exposed hydrophobic regions of unfolded proteins, preventing aggregation and facilitating refolding with co-chaperones (HSP40/DNAJ) and nucleotide exchange factors. Upregulation of HSP70 demonstrates neuroprotection in models of tauopathy and synucleinopathy by limiting β-sheet-rich aggregates and promoting clearance through proteostasis networks. Frontiers

2.2 HSP90

HSP90 stabilizes a wide array of client proteins (kinases, steroid receptors) and interfaces with stress signaling nodes (e.g., NF-κB). In neurodegeneration, HSP90 modulation influences aggregation kinetics and downstream inflammatory cascades. Hyperthermia can synergistically coordinate HSP70 and HSP90 expression to amplify cellular chaperone capacity. Frontiers

2.3 HSP27 and HSP47

HSP27 contributes to cytoskeletal stability and anti-apoptotic signaling, while HSP47, a collagen-specific chaperone, has emerging relevance beyond fibrosis, including thrombo-inflammatory pathways. This underscores the broad systemic roles of HSPs. Thieme

3. Inducing HSPs via Controlled Hyperthermia

3.1 Fever-range hyperthermia and HSP transcription

Thermal stress activates heat shock factor 1 (HSF1), which trimerizes, binds heat shock elements (HSEs), and drives transcription of HSP genes. Whole-body or targeted hyperthermia reproducibly increases HSP70/90, enhances mitochondrial bioenergetics, and downregulates neuroinflammatory mediators. PubMed

3.2 Thermodynamics-guided protocols

Abreu’s discovery of brain thermal tunnels enables brain-guided hyperthermia, allowing precise, safe temperature modulation that induces protective HSP responses while minimizing thermal stress. YaleNews

3.3 Immune modulation crossover

In parallel fields (oncology/immunology), Abreu et al. discuss how hyperthermia augments antigen presentation, DAMP signaling, and T-cell trafficking-mechanistic overlaps that may support neuroimmune homeostasis in addition to neuroprotection. Frontiers

4. Relevance to Neurodegenerative Disease

4.1 Proteostasis restoration

By elevating HSP70/90, controlled hyperthermia can counteract conformational diseases characterized by misfolded proteins (amyloid-β, tau, α-synuclein, TDP-43), promoting refolding or proteolytic removal and mitigating synaptic toxicity. Frontiers

4.2 Mitochondrial and inflammatory axes

HSP induction correlates with improved mitochondrial dynamics (fusion/fission balance) and attenuation of microglial pro-inflammatory signaling, both implicated in disease progression. PubMed

4.3 Clinical observations and translational reports

Emerging translational studies and case series/preprints related to the thermal therapy protocols suggest functional improvements consistent with HSP-mediated mechanisms. While variability exists, these findings support further controlled clinical evaluation. Preprints

5. Brain Thermodynamics and the btt Framework

5.1 Physiologic substrate for noninvasive guidance

Abreu’s Yale report of a “brain thermal tunnel” describes a skin-accessible pathway that transmits core brain thermal signals, establishing an anatomic-physiologic substrate for noninvasive monitoring and guidance of thermodynamic interventions. YaleNews Abreu Brain Thermal Tunnel (ABTT) patents detail btt characteristics that enable coupling between brain core and surface termini. Patentes Google

5.2 Clinical translation

Public disclosures and institutional reports highlight how brain-guided hyperthermia aims to induce HSPs safely and reproducibly within individualized protocols—positioning thermodynamics as a physical lever for neuroprotection. southfloridahospitalnews.com

6. Safety Considerations

Effective HSP induction requires precise control of dose (temperature magnitude), duration, and patient-specific physiology. Protocols should maintain fever-range targets, continuous monitoring, and strict exclusion criteria to mitigate risks (cardiovascular instability, inadequate thermoregulation, etc.). Ongoing peer-reviewed studies are refining thresholds, biomarkers, and patient selection to maximize benefit/risk ratios. Frontiers

7. Discussion

HSPs offer a unifying therapeutic axis across neurodegenerative conditions by restoring proteostasis and damping maladaptive stress responses. While small-molecule HSP co-inducers have shown promise, thermodynamic induction provides a drug-free, systems-level approach that may synergize with pharmacotherapy and neurorehabilitation. The btt framework enables personalized, noninvasive intervention, bridging mechanistic insight with clinical application.

Key next steps include: (i) standardized reporting of temperature dosing and HSP biomarkers; (ii) randomized studies in defined indications (e.g., early Alzheimer’s, ALS motor function endpoints); (iii) integration of neuroimaging, fluid biomarkers, and digital phenotyping to capture multidomain outcomes. Frontiers

8. Conclusion

Recent peer-reviewed work co-authored by M. Marc Abreu supports controlled hyperthermia as a mechanism-based strategy to induce HSPs and counter neurodegenerative cascades. Coupled with brain thermodynamics and btt-guided personalization, HSP induction may restore neural function and quality of life in select patients, warranting further rigorous clinical investigation.

References

1. Smadja DM, Abreu MM . Hyperthermia and targeting heat shock proteins: Innovative Approaches for Neurodegenerative Disorders and Long COVID . Frontiers in Neuroscience. 2025. Open-access review summarizing HSP induction by fever-range hyperthermia and implications for neurodegeneration. Frontiers

2. Abreu MM , Chocron AF, Smadja DM. From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy. Frontiers in Immunology . 2025. Review describing systemic and cellular effects of hyperthermia on immunity, relevant to chaperone biology and inflammation control. Frontiers

3. Smadja DM. Hyperthermia and targeting heat shock proteins. PubMed record summarizing fever-range hyperthermia effects (mitochondria, HSP induction, neuroinflammation). 2025. PubMed

4. Yale University News . Yale Researcher Discovers “Brain Temperature Tunnel” … 2003. Primary institutional announcement of Abreu’s brain thermal tunnel discovery. YaleNews

5. Abreu MM et al. Analysis of temperature signals from an Abreu brain thermal tunnel (ABTT) . Patent/WO2016161355A1 . 2016. Technical disclosure of ABTT for brain-surface thermodynamic communication. Patentes Google

6. South Florida Hospital News. btt CORP. Raises $29.3 Million… 2022; and btt Brain Wellness Institute Announces a Breakthrough… 2025. Context on btt’s translational deployment and statements about brain-guided HSP induction. southfloridahospitalnews.com